Dominion Pharmacal

Dominion Pharmacal is a Canadian pharmaceutical company based in Montreal, Quebec that markets a broad portfolio of authorized generic and branded-generic prescription and non-prescription medicines in Canada. Publicly available Health Canada records show the company as the sponsor for numerous commercialized small-molecule products across multiple therapeutic categories, including gastrointestinal, neurology, urology, and cardiovascular medicines. The company appears to operate as a commercial generics business rather than a clinical-stage biotech, with no evident proprietary R&D pipeline or named platform technology in the reviewed sources. Its product portfolio has included medicines such as lansoprazole, rivastigmine, ropinirole, sildenafil, solifenacin, tadalafil, bupropion, azithromycin, and many other established small-molecule drugs. The available evidence supports classification as an active healthcare company focused on marketed pharmaceutical products in Canada.